Charles Newton

Chief Financial Officer

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

LYEL

CFO

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2023	Lyell Immunopharma, Inc. (LYEL)	Chief Financial Officer	$499,200	$49,920	—	$3,572,687	$187,200	$8,417	$4,317,424
2022	Lyell Immunopharma, Inc. (LYEL)	Chief Financial Officer	$496,172	$1,000,000	—	$2,159,500	$212,160	$7,636	$3,875,468
2021	Lyell Immunopharma, Inc. (LYEL)	Chief Financial Officer	$426,461	$65,096	—	$18,410,845	$216,986	$5,404	$19,124,792
2020	Lyell Immunopharma, Inc. (LYEL)	Chief Financial Officer	—	—	—	—	—	—	—

Earnings-call appearances and filed executive appointments or departures, newest first.